Skip to main content
TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.240
+0.120 (10.71%)
At close: Mar 9, 2026, 4:00 PM EDT
1.220
-0.020 (-1.61%)
After-hours: Mar 9, 2026, 7:27 PM EDT

TScan Therapeutics Revenue

In the year 2025, TScan Therapeutics had annual revenue of $10.33M with 266.65% growth. TScan Therapeutics had revenue of $2.57M in the quarter ending December 31, 2025, with 286.02% growth.

Revenue (ttm)
$10.33M
Revenue Growth
+266.65%
P/S Ratio
6.83
Revenue / Employee
$69,764
Employees
148
Market Cap
70.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202510.33M7.51M266.65%
Dec 31, 20242.82M-18.23M-86.62%
Dec 31, 202321.05M7.51M55.52%
Dec 31, 202213.54M3.39M33.47%
Dec 31, 202110.14M9.06M834.65%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeurAxis 3.36M
ImageneBio 800.00K
Mereo BioPharma Group 500.00K
MediciNova 409.66K
InflaRx 73.73K
eXoZymes -700.00
Revenue Rankings

TCRX News

More News